10. Enter the index of the starting dose level. Note: Index of lowest dose level is always 1. If the design allows for 'minus' dose levels (i.e. -2, -1, etc.), then the index of the starting dose should account for these lower levels (i.e. if -1 dose level allowed, index of starting dose is 2.)
This application simulates operating characteristics for the early-phase method of Wages and Fadul [1].
References:[1] Wages NA, Fadul CE (2019). Adaptive dose finding based on safety and feasibility in early-phase clinical trials of adoptive cell immunotherapy. Clin Trials; [epub ahead of print] Dec 20.
This application computes an updated planned dose level for the next patient in a phase I trial according to the Wages and Fadul method [1].
References:[1] Wages NA, Fadul CE (2019). Adaptive dose finding based on safety and feasibility in early-phase clinical trials of adoptive cell immunotherapy. Clin Trials; [epub ahead of print] Dec 20.
This application computes the safety stopping bounds for the lowest study dose level computed from the posterior distribution of the DLT rate at the lowest dose level based on a beta prior distribution.
This application computes the feasibility stopping bounds computed from the posterior distribution of the feasbility rate at the lowest dose level based on a beta prior distribution.